Diagnostic value of tubular and glomerular biomarkers across different stages of kidney injury in patients with type 2 diabetic nephropathy - Takeaways - MDSpire

Diagnostic value of tubular and glomerular biomarkers across different stages of kidney injury in patients with type 2 diabetic nephropathy

  • By

  • Ming-Zhi Xiao

  • Xin-Xin Pang

  • Di Niu

  • Rui-Fang Chen

  • June 18, 2026

  • 0 min

Share

  • 1

    Diabetic nephropathy (DN) is a leading cause of chronic kidney disease in type 2 diabetes mellitus (T2DM) patients.

  • 2

    Urinary glomerular and tubular biomarkers effectively distinguish DN from controls, even at early kidney function stages.

  • 3

    The urine albumin-to-creatinine ratio (UACR) demonstrated the highest discrimination for DN among individual biomarkers.

  • 4

    Combining UACR with urinary β2-microglobulin and N-acetyl-β-D-glucosaminidase significantly enhances diagnostic performance.

  • 5

    The study highlights the importance of integrating tubular injury markers for improved detection of diabetic kidney damage.

Original Source(s)

Diagnostic value of tubular and glomerular biomarkers across different stages of kidney injury in patients with type 2 diabetic nephropathy

  • by Ming-Zhi Xiao, Xin-Xin Pang, Di Niu, Rui-Fang Chen

  • June 18, 2026

Related Content

A FAERS database study on visual impairment adverse events associated with three long-acting insulin analogues

Widefield SS-OCTA-detected retinal vascular changes and their correlation with DME in diabetes

Anti-Diabetic Retinopathy Molecular Mechanism of Dihuang Yinzi: Insights from Network Pharmacology, Metabolomics, and Microbiome Analysis